The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Today, four out of five HCPs say they’re using LLMs to support clinical decision-making. As these LLM models solidify their ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets ...

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance ...

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications ...

GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in ...